Abstract
The article reviews the literature on current views on pregnancy and hepatitis C virus (HCV), as well as on recent advances in the study of the effects of the disease on pregnancy and pregnancy on the course of the disease. Management of viral hepatitis C during pregnancy requires an assessment of the risk of transmission to the child, determining the age of gestation at the time of infection and the risk of maternal decompensation, as well as awareness of the side effects of antiviral drugs. Purpose - to analyze new data from the literature of different countries to determine the main problem of management of pregnant women with hepatitis C. Results and conclusions. Numerous studies by scientists in different countries agree on the possible complications of pregnancy during its course on the background of CHC, there is new information about the pathogenesis of damage to the placenta, fetus. However, the available effective treatments are completely contraindicated for pregnant women, for breastfeeding women, as well as for women planning to become pregnant in the next 12 months. That is why the problem of hepatitis C in the modern world must continue to be studied. It is also important to increase screening for at-risk groups, to increase the percentage of identified sick women and to introduce active preventive treatment for women planning a pregnancy. No conflict of interests was declared by the authors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
